Amarillo Biosciences competitorsClear all

Amarillo Biosciences's top competitors include Obsidian Therapeutics, Z Factor, Mymetics and Elite Pharmaceuticals.
Amarillo Biosciences
Amarillo Biosciences
Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinical trials with a well-characterized therapeutic agent, interferon-alpha, in a proprietary low-dose oral formulation.
Obsidian Therapeutics
Obsidian Therapeutics
Obsidian Therapeutics aspires to extend adoptive immunotherapy to every patient with cancer.
Z Factor
Z Factor
Z Factor Limited is a drug discovery company.
Mymetics
Mymetics
Mymetics develops nex-generation prophylactic vaccines for infectious diseases.
Elite Pharmaceuticals
Elite Pharmaceuticals
Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.
Founding Date
Founding Date
N/A
Founding Date
2015
Founding Date
2014
Founding Date
1994
Founding Date
N/A
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Amarillo, US HQ
Locations
Cambridge, US HQ
Locations
Cambridgeshire, GB HQ
Locations
Épalinges, CH HQ
Locations
Northvale, US HQ
Employees
Employees
433% increase
Employees
474% decrease
Employees
4
Employees
5
Employees
3519% decrease
Valuation ($)
Valuation ($)
6.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
21.3 m
Valuation ($)
68.3 m
Alexa Website Rank
Alexa Website Rank
1157370
Alexa Website Rank
760795
Alexa Website Rank
N/A
Alexa Website Rank
142655
Alexa Website Rank
923284

Financial

Revenue (est.)
Revenue (est.)
$77.7k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$967 (FY, 2018)
Revenue (est.)
$7.6m (FY, 2019)
Cost of goods
Cost of goods
$64.9k (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$4.7m (FY, 2019)
Gross profit
Gross profit
$12.8k (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$2.9m (FY, 2019)
Net income
Net income
($1.3m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
($4.2k) (FY, 2018)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 49.5m (almost 2 years ago)
Latest funding round
$ 9.1m (over 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 49.5m
Total funding raised
$ 9.1m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Obsidian Therapeutics
HQ
Cambridge, US
Employees
47↓ 4% decrease

Obsidian Therapeutics aspires to extend adoptive immunotherapy to every patient with cancer.

View company
Z Factor
HQ
Cambridgeshire, GB
Employees
4

Z Factor Limited is a drug discovery company.

View company
Mymetics
HQ
Épalinges, CH
Employees
5

Mymetics develops nex-generation prophylactic vaccines for infectious diseases.

View company
Elite Pharmaceuticals
HQ
Northvale, US
Employees
35↓ 19% decrease

Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.

View company